tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Graham Parry, 3 are a HOLD (42.86%), 1 are a SELL (14.29%), 3 are a BUY (42.86%).
Analyst Graham Parry, currently employed at BAML, carries an average stock price target met ratio of 16.67% that have a potential upside of 31.69% achieved within 1726 days.
Graham Parry’s has documented 12 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVS, Novartis AG ADR at 12-Sep-2023.
Analyst best performing recommendations are on GSK (GLAXOSMITHKLINE PLC ADR).
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
22.07
18 days ago
0/14 (0%)
$-16.41 (-42.65%)
Buy
53
$13.65 (34.69%)
48
24 days ago
2/4 (50%)
$14.79 (38.71%)
368
Hold
44
$4.65 (11.82%)
18.72
6 months 3 days ago
1/14 (7.14%)
$5.42 (14.05%)
107
Hold
19.52
$-19.83 (-50.39%)
18.9
11 months 12 days ago
0/3 (0%)
$-14.59 (-42.77%)
Hold
19.58
$-22.45 (-53.41%)
19.96
1 years 3 months 5 days ago
0/2 (0%)
$-16.05 (-45.05%)
What Year was the first public recommendation made by Graham Parry?
